title: Addiction treatment: level of care determination.
abstract: Substance use disorders occur in 10% to 20% of patients presenting to the primary care physician. It is estimated that every fifth patient in a primary care practice has a substance use disorder. One of the challenges for the primary care physician after the initial assessment is a referral to the appropriate level of care. Substance abuse treatment is now a multibillion dollar industry, and there are a wide variety of options for those with resources. Most patients depend on community resources and state- and county-funded programs.
authors.affiliation: Optum Health Behavioral Solutions, Suite 300, 1900 East Golf Road, Schaumburg, IL 60173, USA; Central DuPage Hospital, 27 West 350 Highlake Road, Winfield, IL 60190, USA; University of Illinois at Chicago, Chicago, IL, USA. Electronic address: Danesh_Alam@cdh.org.
authors.forename: Danesh A
authors.initials: DA
authors.lastname: Alam
authors.affiliation: Optum Health Behavioral Solutions, Suite 300, 1900 East Golf Road, Schaumburg, IL 60173, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Martorana
mesh_terms: D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000627:therapeutic use; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D006305:Health Status Indicators; D006801:Humans; D007297:Inpatients; D008403:Mass Screening; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010045:Outpatients; D011320:Primary Health Care / Q000379:methods*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000427:Alcohol Deterrents; D009292:Narcotic Antagonists; D013654:Taurine; D009271:Naltrexone; D000077443:Acamprosate